Verve Medical, Inc

Quick facts

Phase 1 pipeline

• Active hypertension medical therapy · Cardiovascular
  Blocks the action of angiotensin II at the AT1 receptor

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Verve Medical, Inc portfolio CI brief
• Verve Medical, Inc pipeline updates RSS